Register for an account

X

Enter your name and email address below.

Your email address is used to log in and will not be shared or sold. Read our privacy policy.

X

Website access code

Enter your access code into the form field below.

If you are a Zinio, Nook, Kindle, Apple, or Google Play subscriber, you can enter your website access code to gain subscriber access. Your website access code is located in the upper right corner of the Table of Contents page of your digital edition.

Mind

‘Incidentalomas’ and Stage Zero Cancer -- A Semantic Dilemma with Medical Consequences

Fire in the MindBy George JohnsonJuly 30, 2013 5:57 AM

Newsletter

Sign up for our email newsletter for the latest science news

One of the measures by which oncologists describe the severity of a malignancy is according to its stage, with Stage 4 being the most deadly. There is a certain amount of arbitrariness to the labeling scheme, and the details vary according to the type of cancer. But Stage 4 refers, in general, to those that have spread, or metastasized, beyond the original site -- to a distant lymph node or organ. Advanced Stage 4 cancers are almost never curable, and the treatments can be so devastating that it is often not clear whether a few extra months of life is something to be desired. Then there are what the doctors call Stage 0 -- abnormal cells that may or may not ever become a problem. Tara Parker Pope wrote about these today in the New York Times, and she introduces a term I hadn’t encountered before: incidentalomas — “the name given to incidental findings detected during medical scans that most likely would never cause a problem.” Some of these, many oncologists and researchers are coming to believe, should not even be called cancer. The word is so terrifying that it leads to overtreatment, which can have its own dangerous side-effects. The occasion for the piece, which is posted in the Well blog, is a commentary published today in the Journal of the American Medical Association: “Overdiagnosis and Overtreatment in Cancer.”

The word “cancer” often invokes the specter of an inexorably lethal process; however, cancers are heterogeneous and can follow multiple paths, not all of which progress to metastases and death, and include indolent disease that causes no harm during the patient’s lifetime.

Examples include ductal carcinoma in situ, early prostate cancer, and Barrett’s esophagus, which can lead, though it hardly ever does, to cancer of the esophagus. The dilemma is that for any individual case, there is no reliable way to determine whether the suspicious cells will later evolve into a true malignancy. Parker Pope’s thoughtful discussion of the issues has attracted an enviable number of intelligent comments from readers. This one is my favorite:

Overtreatment is when someone else has something that might be cancer. When you have it, well, I'm guessing most people would want it out.

However low the odds, once a true cancer manifests itself, it is there 100 percent. For a preview of The Cancer Chronicles, including the table of contents and index, please see the book’s website. @byGeorgeJohnson

    2 Free Articles Left

    Want it all? Get unlimited access when you subscribe.

    Subscribe

    Already a subscriber? Register or Log In

    Want unlimited access?

    Subscribe today and save 70%

    Subscribe

    Already a subscriber? Register or Log In